Allarity Therapeutics, Inc. (ALLR)
ALLRNASDAQ-CMBiotechnology: Pharmaceutical Preparations
$0.9400
+0.0267 (+2.92%) today
Closed, Nov 10, 4:00 PM ET
- Market cap
- $14.48m
- P/E
- –
- EPS, last 4 quarters
- $-0.7800
- Dividend yield
- –
- Day range
- –
- 52-week range
- $0.7687 to $1.84
- Average volume
- 127.1k
- Previous close
- $0.9133
Analysts
1 coveringHold1 buy, 0 hold, 0 sell
Targets a year out average $11.00, +1070.2% from here
Earnings
next estimate $-0.2100Next report Nov 13, 2026
Sep 2025
+17.4%
Dec 2025
+4.5%
Mar 2026
+22.7%
Jun 2026
+16.0%
estimate reported, and the surprise
Financials
| Quarter | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| Revenue | – | $320.0k | $25.0k | – |
| Gross profit | – | $320.0k | $25.0k | – |
| Operating income | -$2.52m | -$2.92m | -$2.69m | -$2.67m |
| Net income | -$2.81m | -$3.37m | -$2.75m | -$3.40m |
News
8 latest- Allarity Therapeutics Signs First Revenue-Generating CLIA Services Deal; Stock Down RTTNews · Oct 30, 2026
- Here's Why Allarity Therapeutics, Inc. (ALLR) Is a Great 'Buy the Bottom' Stock NowZacks · Oct 9, 2026
- Valion Chair Jensen Outlines Focus On Entolimod Development; Stock Down RTTNews · Oct 5, 2026
- Allarity Gets Japanese Patent For Stenoparib DRP Companion Diagnostic; Protection Through 2039 RTTNews · Sep 15, 2026
- Allarity Q2 Loss Expands On Higher Expenses; Stock Down RTTNews · Aug 19, 2026
- Are Medical Stocks Lagging Allarity Therapeutics, Inc. (ALLR) This Year?Zacks · Jul 22, 2026
- Is Allarity Therapeutics, Inc. (ALLR) Stock Outpacing Its Medical Peers This Year?Zacks · Jul 6, 2026
- Is Allarity Therapeutics, Inc. (ALLR) Outperforming Other Medical Stocks This Year?Zacks · Jun 19, 2026
The company
Allarity Therapeutics, Inc. (NASDAQ: ALLR) is a clinical-stage pharmaceutical company focused on developing personalized cancer treatments. The Company is developing stenoparib, a novel PARP/tankyrase inhibitor for patients with advanced ovarian cancer, and is using its proprietary DRP technology to develop a companion diagnostic designed to identify patients expected to derive the greatest clinical benefit from stenoparib. Allarity's principal operations are located in Denmark , and its U.S . business address is in Florida . For more information, visit www.allarity.com .
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Exchange
- NASDAQ-CM
- Region
- North America
- Website
- allarity.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.